Companies › RLYB
Rallybio Corp (RLYB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001739410 · EDGAR filings · Updated 2026-07-15
Rallybio Corp (RLYB) has reported institutional ownership of 88.2%, with 38 institutional managers holding positions valued at $41.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-15 — S-4 filed
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-06-05 — SCHEDULE 13G filed
- 2026-06-01 — 425 filed
- 2026-06-01 — Current report (8-K) filed
- 2026-05-20 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Rallybio Corp has 38 institutional holders and institutional ownership of 88.2%.
Insider activity
Insiders reported 2 transactions (0 buys, 1 sells) across 2 reporting insiders, with a net reported value of −$3.99K.
Data flags from SEC filings
Related companies
ATYR PHARMA INC (ATYR) · Adicet Bio Inc (ACET) · SATELLOS BIOSCIENCE INC (MSLE) · GREENWICH LIFESCIENCES INC (GLSI) · PULMONX CORP (LUNG) · LUCID DIAGNOSTICS INC (LUCD)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.